Tagged: alphafold
5 results
Salt AI
Salt AI is a Los Angeles contextual-AI company building a visual platform that lets regulated enterprises - especially life sciences and healthcare teams - orchestrate many AI models into governed, auditable workflows that run inside their own infrastructure. Founded in 2023 by former Myspace CTO Aber Whitcomb and Jim Benedetto, Salt lets biochemists and clinicians drag, drop, and chain models like AlphaFold2 (which Salt runs 22x faster), ProteinMPNN, and Chroma without writing code, turning months of pipeline engineering into weeks while keeping every prompt, weight, and response logged for compliance.
Michelle Lee
Michelle Lee is the founder and CEO of Medra, a San Francisco company building 'Physical AI Scientists' - robot arms with cameras and sensors, governed by AI, that run wet-lab biology experiments around the clock. A Stanford AI Lab PhD who worked at NVIDIA, SpaceX, and McKinsey, she walked away from an assistant professor post at NYU after AlphaFold 2's 2021 release convinced her that biology's real bottleneck was not algorithms but data, and that data is a robotics problem. Medra runs in production with partners including Genentech and raised a $52M Series A in December 2025, bringing total funding to roughly $63M.
Deniz Kavi
Deniz Kavi is the co-founder and CEO of Tamarind Bio, a San Francisco company that turns hundreds of complex computational-biology models - AlphaFold, RFdiffusion, OpenFold and more - into a point-and-click web tool and API so scientists can design drug candidates without writing code or wrangling cloud infrastructure. A Stanford computer-science graduate who did computational-biology research and engineered software at Stanford School of Medicine, he started the company in 2023 with co-founder Sherry Liu, went through Y Combinator's W24 batch, and in February 2026 raised a $13.6M Series A led by Dimension Capital. Tamarind now serves 10,000+ scientists, including 8 of the top 20 global pharma companies, and was tapped to run the inference infrastructure behind Eli Lilly's TuneLab 2.0.
Tamarind Bio
Tamarind Bio is a San Francisco software company building cloud infrastructure that lets bench scientists run 250+ AI and physics-based models for drug discovery - tools like AlphaFold, RFdiffusion, ProteinMPNN and GROMACS - through a no-code web interface and API, without managing GPUs, data pipelines or DevOps. Founded in 2023 by Stanford computer scientist Deniz Kavi and Sherry Liu, the company serves over 10,000 scientists, including 8 of the top 20 pharmaceutical companies, and raised a $13.6M Series A in February 2026.
Demis Hassabis
Sir Demis Hassabis CBE FRS is a British AI researcher, neuroscientist, chess prodigy, and game designer who co-founded DeepMind in 2011 and serves as CEO of Google DeepMind. He won the 2024 Nobel Prize in Chemistry for AlphaFold's protein structure prediction, was knighted for services to AI, and is widely regarded as one of the most influential figures in the development of artificial general intelligence.